Cargando…
Transmembrane channel activity in human hepatocytes and cholangiocytes derived from induced pluripotent stem cells
The initial creation of human‐induced pluripotent stem cells (iPSCs) set the foundation for the future of regenerative medicine. Human iPSCs can be differentiated into a variety of cell types in order to study normal and pathological molecular mechanisms. Currently, there are well‐defined protocols...
Autores principales: | Florentino, Rodrigo M., Li, Qin, Coard, Michael C., Haep, Nils, Motomura, Takashi, Diaz‐Aragon, Ricardo, Faccioli, Lanuza A. P., Amirneni, Sriram, Kocas‐Kilicarslan, Zehra N., Ostrowska, Alina, Squires, James E., Feranchak, Andrew P., Soto‐Gutierrez, Alejandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234678/ https://www.ncbi.nlm.nih.gov/pubmed/35289126 http://dx.doi.org/10.1002/hep4.1920 |
Ejemplares similares
-
Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target
por: Motomura, Takashi, et al.
Publicado: (2021) -
From a Single Cell to a Whole Human Liver: Disease Modeling and Transplantation
por: Motomura, Takashi, et al.
Publicado: (2022) -
Molecular overview of progressive familial intrahepatic cholestasis
por: Amirneni, Sriram, et al.
Publicado: (2020) -
Bile acids stimulate cholangiocyte fluid secretion by activation of transmembrane member 16A Cl(−) channels
por: Li, Qin, et al.
Publicado: (2018) -
Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic Variants
por: Faccioli, Lanuza A. P., et al.
Publicado: (2023)